https://scholars.lib.ntu.edu.tw/handle/123456789/537167
標題: | Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in healthy adolescents on two-dose schedule | 作者: | Chen C.-C. MEI-HWEI CHANG Lee H.-C. Twu S.-J. Safary A. |
關鍵字: | Adverse reaction; Dose; Hepatitis B vaccine; Immunogenicity | 公開日期: | 1999 | 卷: | 40 | 期: | 3 | 起(迄)頁: | 157-160 | 來源出版物: | Acta Paediatrica Sinica | 摘要: | This is an open, randomized study to compare the immunogenicity and reactogenicity of two recombinant hepatitis B virus (HBV) vaccines. The HBV- NF is a new formulation with a new adjuvant phenoxyethanol which replaced the conventional adjuvant of a commercially available recombinant HBV vaccine (Engerix-B). These two vaccines had the same 20 μ g hepatitis B surface antigen (HBsAg). They were administered to the deltoid muscle of 116 healthy adolescents, aged between twelve and eighteen years, according to the 0, 6- month schedule. Serum was taken at month 1, 1, 6, and 7. Antibody to HBsAg was tested by radioimmunoassay. Geometric mean titers of both vaccines displayed no significant difference at month 1, 6, and 7. Following the second dose of vaccine, the seroprotection titer (10 mIU/ml) rates at month 7 were 90.9% in HBV-NF and 93.4% in Engerix, B, respectively (p = 0.43). The incidences of local and general adverse reactions were from 3% to 7% without significant difference between the two vaccines and the reactions were all mild and tolerable. Based on this study, regimens of this two-dose schedule proved to be safe and immunogenic, which may provide a cost-effective alternative for HBV mass vaccination program in adolescents. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032801327&partnerID=40&md5=57104fc92f5b8a0af3e35a100659c6cd https://scholars.lib.ntu.edu.tw/handle/123456789/537167 |
ISSN: | 0001-6578 | SDG/關鍵字: | 2 phenoxyethanol; hepatitis b surface antibody; hepatitis b surface antigen; hepatitis b vaccine; recombinant hepatitis b vaccine; adolescent; antibody titer; article; clinical trial; controlled clinical trial; controlled study; cost benefit analysis; female; gastrointestinal symptom; headache; hepatitis b; human; immunogenicity; immunoreactivity; inflammation; intramuscular drug administration; major clinical study; malaise; male; pain; radioimmunoassay; randomized controlled trial; vaccination; Adolescent; Cost-Benefit Analysis; Female; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunization Schedule; Male; Statistics, Nonparametric; Vaccines, Synthetic |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。